Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
The text messages motivate Christian Collins to keep inspiring others. One told the USC-bound forward about three family ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Darren White, 53, was given steroids when tests showed his body was rejecting his new lung three months after his transplant.
Darren White, a former bus driver from Stockton, was one of the first lung transplant patients to have a skin patch from ...
Darren White was one of the first lung transplant patients to have a skin patch from a donor grafted on to their skin.
Lung transplantation for lung cancer remains exploratory but may benefit patients with concurrent end-stage lung disease. We present a 47-year-old Asian male with Hermansky-Pudlak syndrome-associated ...
Idiopathic pulmonary fibrosis, a rare progressive disease characterized by fibrosis in the alveoli of the lungs, has a median survival of 3 to 5 years if left untreated. Inhaled treprostinil slowed ...
Travis Corbitt knew he wasn't in the best shape, but he didn't understand why he felt like he could never catch his breath. He had been a police officer for more than 40 years, but chasing down ...
LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of immune cell modulators for the ...
Jascayd (nerandomilast) is a brand-name prescription oral tablet used to treat idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults by reducing inflammation and slowing lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results